Financials
Financial year 2025
Worth noting
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Gross margin
€ -72,254
▲ 52% vs 2024
Profit
Caution€ -111,132
▲ 57% vs 2024
Debts
Low€ 1.2 million
▼ 13% vs 2024
CURAVAC EUROPE from Rixensart, company number BE0479403989, closed financial year 2025 with a result of € -111,132 after tax. For that financial year CURAVAC EUROPE recorded a gross margin of € -72,254 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € -257,915 to € -111,132. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.
What happened at CURAVAC EUROPE?
What happened at CURAVAC EUROPE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- FRANCOIS MAIRLOT stepped down as director. NBB
- LEONE FLYNN stepped down as director. NBB
- ZYTHUM SA stepped down as director. NBB
- STEPHANE HUBERTY stepped down as director. NBB
- JPP CONSULTING SRL stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 111,132. Source: NBB ↗
- FRANCOIS MAIRLOT became a director. NBB
- LEONE FLYNN became a director. NBB
In short
From € 92,822 loss in 2022 to € 111,132 loss in 2025.
A new publication or filing at CURAVAC EUROPE? We notify you, reason included.
Follow CURAVAC EUROPENeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Director · represented by NICOLAS HAVELANGE
since 2022 · until 2028
STEPHANE HUBERTY
Managing director
since 2022 · until 2028
since 2024 · until 2030
Director · represented by JEAN-PAUL PRIEELS
Also active at: PDC line Pharma, ConvEyXo, XomeXBio +1 more
since 2022 · until 2028
since 2024 · until 2030
Establishments
Establishment units
Physical locations of this company
Avenue de Villefranche 80
1330 Rixensart
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0479.403.989
- VAT number
- BE 0479.403.989
- Registered office
- Avenue de Villefranche 80, 1330 Rixensart
- Names & denominations
- CURAVAC EUROPE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 28 January 2003
- Peppol
- Active · Active since 26 Nov 2025
- Activities · NACE
Vervaardiging van farmaceutische grondstoffen